Are you or your company involved in the development of nasal products? If so, this should interest you:
The European Medicines Agency has just released a “Concept paper for the development of a guideline on the demonstration of therapeutic equivalence for nasal products” for public consultation. Interested parties are invited to review and comment with a deadline for comments by 31 October 2024. The concept paper can be found on the EMA website.
Information kindly provided by Louise Rosenmayr-Templeton.